Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DCPS | Q96C86 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | HTR2C | P28335 | 2/20 | 0.38 |
| ▸ | HTR2B | P41595 | 2/20 | 0.38 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.37 |
| ▸ | SCN9A | Q15858 | 7/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20201732 | 0.86 | DCPS (0.38) | DCPSHTR2AHTR2CHTR2BRIPK1 | |
| SCHEMBL20201698 | 0.83 | HTR2A (0.36) | DCPSHTR2AHTR2CHTR2BRIPK1 | |
| SCHEMBL11962822 | 0.79 | HTR2A (0.43) | HTR2AHTR2CHTR2BRIPK1FFAR4 | |
| SCHEMBL14199446 | 0.79 | HTR2A (0.38) | HTR2AHTR2CHTR2BRIPK1SCN9A | |
| SCHEMBL765009 | 0.79 | GRM2 (0.43) | DCPSHTR2AHTR2CHTR2BRIPK1 | |
| SCHEMBL21325087 | 0.79 | RIPK1 (0.41) | HTR2AHTR2CHTR2BRIPK1SCN9A | |
| SCHEMBL17855228 | 0.77 | KDM4E (0.36) | — | |
| SCHEMBL9250854 | 0.77 | SCN9A (0.36) | HTR2AHTR2CHTR2BRIPK1SCN9A | |
| SCHEMBL9250852 | 0.77 | SCN9A (0.36) | HTR2AHTR2CHTR2BRIPK1SCN9A | |
| SCHEMBL20862552 | 0.76 | SCN9A (0.41) | HTR2AHTR2CHTR2BSCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018098206-A1 | HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS | CV6 THERAPEUTICS (NI) LIMITED (GB) | 2018-05-31 | — | — | WO | disclosed |